These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 9621132)
1. Alteration of cytokine genes and bcl-2 expression following immunotherapy with intralesional IFN-gamma in a patient with tumor-stage mycosis fungoides. Yamamoto T; Takahashi Y; Katayama I; Nishioka K Dermatology; 1998; 196(3):283-7. PubMed ID: 9621132 [TBL] [Abstract][Full Text] [Related]
3. Cytokine profile of tumor cells in mycosis fungoides: successful treatment with intra-lesional interferon-gamma combined with chemotherapy. Yamamoto T; Sasaki G; Sato T; Katayama I; Nishioka K J Dermatol; 1995 Sep; 22(9):650-4. PubMed ID: 8537550 [TBL] [Abstract][Full Text] [Related]
4. Tumor-associated M2 macrophages in mycosis fungoides acquire immunomodulatory function by interferon alpha and interferon gamma. Furudate S; Fujimura T; Kakizaki A; Hidaka T; Asano M; Aiba S J Dermatol Sci; 2016 Sep; 83(3):182-9. PubMed ID: 27342040 [TBL] [Abstract][Full Text] [Related]
5. Cytokine gene polymorphisms in patch-stage mycosis fungoides. Hodak E; Akerman L; David M; Tambur AR; Kfir B; Maron L; Sulkes J; Klein T Acta Derm Venereol; 2005; 85(2):109-12. PubMed ID: 15823901 [TBL] [Abstract][Full Text] [Related]
6. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas. Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809 [TBL] [Abstract][Full Text] [Related]
7. Immune function abnormalities in peripheral blood mononuclear cell cytokine expression differentiates stages of cutaneous T-cell lymphoma/mycosis fungoides. Chong BF; Wilson AJ; Gibson HM; Hafner MS; Luo Y; Hedgcock CJ; Wong HK Clin Cancer Res; 2008 Feb; 14(3):646-53. PubMed ID: 18245523 [TBL] [Abstract][Full Text] [Related]
8. Interferon (IFN)-gamma , tumor necrosis factor-alpha , interleukin-6, and IFN-gamma receptor 1 are the major immunological determinants associated with post-kala azar dermal leishmaniasis. Ansari NA; Ramesh V; Salotra P J Infect Dis; 2006 Oct; 194(7):958-65. PubMed ID: 16960784 [TBL] [Abstract][Full Text] [Related]
9. Progression of mycosis fungoides is associated with increasing cutaneous expression of interleukin-10 mRNA. Asadullah K; Döcke WD; Haeussler A; Sterry W; Volk HD J Invest Dermatol; 1996 Dec; 107(6):833-7. PubMed ID: 8941670 [TBL] [Abstract][Full Text] [Related]
10. Bcl-2 expression in mycosis fungoides before and after PUVA therapy. Weshahy H; Mahgoub D; El-Eishy N; El-Tawdy AM; Bassiouny DA; Hunter N; Hindawi A Photodermatol Photoimmunol Photomed; 2010 Apr; 26(2):107-9. PubMed ID: 20415745 [TBL] [Abstract][Full Text] [Related]
11. Low-Dose Intralesional Recombinant Interferon-α2b in the Treatment of Mycosis Fungoides. Hu JK; Carlson K; Girardi M Yale J Biol Med; 2020 Mar; 93(1):41-44. PubMed ID: 32226334 [TBL] [Abstract][Full Text] [Related]
12. Interleukin 4 and interferon-gamma expression of the dermal infiltrate in patients with erythroderma and mycosis fungoides. An immuno-histochemical study. Sigurdsson V; Toonstra J; Bihari IC; Bruijnzeel-Koomen CA; van Vloten WA; Thepen T J Cutan Pathol; 2000 Oct; 27(9):429-35. PubMed ID: 11028812 [TBL] [Abstract][Full Text] [Related]
13. Alterations of serum Th1 and Th2 chemokines by combination therapy of interferon-gamma and narrowband UVB in patients with mycosis fungoides. Shimauchi T; Sugita K; Nishio D; Isoda H; Abe S; Yamada Y; Hino R; Ogata M; Kabashima K; Tokura Y J Dermatol Sci; 2008 Jun; 50(3):217-25. PubMed ID: 18243665 [TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha is effective for CD4(+), CCR4(-) mycosis fungoides. Fujimura T; Okuyama R; Watabe A; Hashimoto A; Tagami H; Aiba S Int J Dermatol; 2007 Apr; 46(4):435-8. PubMed ID: 17442093 [TBL] [Abstract][Full Text] [Related]
15. A correlation between acute phase proteins and cytokines in patients suffering from mycosis fungoides. Pawlaczyk M; Sobieska M Acta Dermatovenerol Alp Pannonica Adriat; 2006 Sep; 15(3):107-12. PubMed ID: 17053844 [TBL] [Abstract][Full Text] [Related]
16. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways. Wozniak MB; Tracey L; Ortiz-Romero PL; Montes S; Alvarez M; Fraga J; Fernández Herrera J; Vidal S; Rodriguez-Peralto JL; Piris MA; Villuendas Deceased R Br J Dermatol; 2009 Jan; 160(1):92-102. PubMed ID: 18945306 [TBL] [Abstract][Full Text] [Related]
17. Phenotypic Variation in Different Lesions of Mycosis Fungoides Biopsied Within a Short Period of Time From the Same Patient. Kash N; Massone C; Fink-Puches R; Cerroni L Am J Dermatopathol; 2016 Jul; 38(7):541-5. PubMed ID: 26885605 [TBL] [Abstract][Full Text] [Related]
18. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside. O'Malley BW; Li D; McQuone SJ; Ralston R Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147 [TBL] [Abstract][Full Text] [Related]
19. Treatment with IFN-gamma increases serum levels of Th1 chemokines and decreases those of Th2 chemokines in patients with mycosis fungoides. Hino R; Shimauchi T; Tokura Y J Dermatol Sci; 2005 Jun; 38(3):189-95. PubMed ID: 15927812 [TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of BCL11B in mycosis fungoides and its potential role in interferon-induced apoptosis. Gu X; Wang Y; Zhang G; Li W; Tu P J Dermatol; 2013 Aug; 40(8):596-605. PubMed ID: 23682716 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]